+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

In vitro modeling of the influence of FVIII activity and heparin induced prolongation of APTT

In vitro modeling of the influence of FVIII activity and heparin induced prolongation of APTT

Bosnian Journal of Basic Medical Sciences 5(3): 26-29

Anticoagulant therapy is most commonly assessed by measuring the effect of the drug on global clotting assay, such as APTT. It is known that response of the APTT to heparin may be decreased in patients with high levels of factor VIII. In this work, we have attempted to determine in vitro conditions of experiment for obtaining relationship between different concentrations of heparin and values of APTT, and to investigate influence of factor VIII on correlation between concentrations of heparin and APTT. Measurement of the effect of heparin, added in vitro in normal coagulation control plasma (NCCP) showed that heparin in concentrations from 0.1 to 1.0 IU/mL prolonged APTT from 0.73 s to 99.26 s. Linearity of the relation of natural logarithm of APTT and concentration of added heparin in plasma for concentrations from 0.5 to 1.0 IU/mL (r = 0.995), and other characteristics of the validated method (RSD = 1.17%), made possible investigation of the influence of factor VIII addition in the solution. The addition of the Factor VIII concentrate, markedly influenced these APTT results. Increased factor VIII activity shortened the APTT, having more pronounced effect in the presence of the large amounts of heparin. Increased factor VIII was associated with downward shift in the concentration -- logAPTT response curve (y = 24644 x + 30.17 vs. y = 10.864 x + 27.256). This finding suggests the possibility for modeling of ex vivo establishment of correlation between plasma activity of FVIII and needed doses of heparin for appropriate management of heparin therapy.

Please choose payment method:

(PDF emailed within 1 workday: $29.90)

Accession: 049316437

Download citation: RISBibTeXText

PMID: 16351577

Related references

Comparison of heparin-induced prolongation of APTT in 12 different laboratories in Kyushu area. Rinsho Byori. Japanese Journal of Clinical Pathology 61(7): 576-582, 2013

In vitro FVIII-induced IL-10 production accompanies in vivo development of FVIII-inhibitors in children with severe hemophilia treated with recombinant FVIII. Blood 90(10 Suppl. 1 Part 2): 133B, 1997

Comparison of two APTT methods of monitoring heparin therapy. APTT ratio and heparin response of pooled normal plasma. American Journal of Clinical Pathology 93(5): 684-689, 1990

Monitoring unfractionated heparin with APTT: a French collaborative study comparing sensitivity to heparin of 15 APTT reagents. Thrombosis Research 129(5): 666-667, 2012

Untersuchungen zur Heparin-Empfindlichkeit" verschiedener APTT-Reagenzien: Ist die Ermittlung an einem Normalplasmapool ausreichend?. Studies on the "Heparin Sensitivity" of Various APTT Reagents: Is the Use of a Normal Plasma Pool Sufficient?. Laboratoriums Medizin 22(3): 157-164, 1998

Use of anti-X a activity as a marker for heparin-induced bleeding in patients with APTT > 180 s. Clinical Chemistry 43(9): 1781-1782, 1997

Neutralizing capacity of inhibitors on FVIII is lower for natural FVIII/VWF complex than for isolated FVIII: in vitro comparative study in eleven different therapeutic FVIII concentrates. Haemophilia 22(4): E341-E344, 2016

Discrepant factor VIII activity in a family with mild haemophilia A and 531 mutation using various FVIII assays and APTT reagents. Haemophilia 11(5): 561-564, 2005

Reversal of heparin-induced increases in aPTT in the rat by PM102, a novel heparin antagonist. European Journal of Pharmacology 635(1-3): 165-170, 2010

Influence of the factor VIII:C-activity on the activated partial thromboplastin time (aPTT) in dogs. Usefulness of the aPTT as a screening test for canine haemophilia A?. Deutsche Tieraerztliche Wochenschrift 100(6): 219-222, 1993

Lack of correlation between aPTT, anti-Xa activity, and heparin dose in children receiving therapeutic doses of unfractionated heparin. Pediatric Research 53(4 Part 2): 284A, 2003

Evaluation of the activity levels of rat FVIII and human FVIII delivered by adeno-associated viral vectors both in vitro and in vivo. Blood Cells Molecules and Diseases 73: 47-54, 2018

Monitoring heparin treatment with the APTT: The effect of methodological changes on the APTT. Netherlands Journal of Medicine 49(1): 13-18, 1996

The utility of activated partial thromboplastin time (aPTT) clot waveform analysis in the investigation of hemophilia A patients with very low levels of factor VIII activity (FVIII:C). Thrombosis and Haemostasis 87(3): 436-441, 2002

Applying a direct aPTT ratio (PlatelinLS/ActinFS) permits to identify rapidly and reliably a bleeding-related factor deficiency or a lupus anticoagulant sequential to an isolated prolongation of aPTT in paediatric pre-operative screening. European Journal of Haematology 96(6): 578-585, 2016